Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03479242 · ClinicalTrials.gov registry record
Diabetic Foot Ulcer Recurrence: Pilot Study
A clinical trial, sponsored by Indiana University.
- Terminated
- Registry status
- 15
- Enrollment target
NCT03479242 is a clinical trial that was terminated before completion, run by Indiana University. The registered enrollment target is 15 participants.
The verdict
NCT03479242 was terminated before completion, sponsored by Indiana University.
- TERMINATED
- Registry status
- 15 participants
- Enrollment target
Study Summary
In this prospective pilot study, patients with DFU visiting the Indiana University Comprehensive Wound Center will be enrolled. Patients enrolled in the study will be followed for 16 weeks for wound closure(Phase A), and will then begin Phase B where TEWL measurements and wound recurrence will be followed up for up to 12 weeks.
Interventions
- OTHER no interventions
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 15 participants |
| Start Date | 2019-01-25 |
| Est. Completion | 2023-08-30 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03479242
The ClinicalTrials.gov registry entry for NCT03479242 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 15 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Indiana University, which has 890 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which no interventions is the first listed.
NCT03479242 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03479242 about?
NCT03479242 is a clinical study titled "Diabetic Foot Ulcer Recurrence: Pilot Study". In this prospective pilot study, patients with DFU visiting the Indiana University Comprehensive Wound Center will be enrolled. Patients enrolled in the study will be followed for 16 weeks for wound closure(Phase A), and will then begin Phase B where TEWL measurements and wound recurrence will be fo...
What is the current status of trial NCT03479242?
This trial is currently terminated. The enrollment target is 15 participants. The study started on 2019-01-25. Estimated completion is 2023-08-30.
What interventions are being tested in trial NCT03479242?
The interventions under investigation include: no interventions (OTHER).
Who is sponsoring clinical trial NCT03479242?
This trial is sponsored by Indiana University, which has 890 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.